Nurse-Led Intrinsic Capacity Screening in Community Settings

Abstract

Intrinsic capacity (IC), a multidimensional concept encompassing physical and mental capacities, has emerged as a central focus in geriatric medicine and healthy aging strategies. This review explores the scientific rationale, clinical implications, and practical implementation of nurse-led intrinsic capacity screening in community settings. Drawing on recent evidence and global guidelines, the article examines the epidemiology of declining IC, underlying mechanisms, risk factors, clinical presentation, diagnostic approaches, and management strategies. Special emphasis is placed on the integration of nurse-led assessments within primary care and community health frameworks, the latest advances in screening tools, and their potential to inform personalized interventions, prevent functional decline, and improve health outcomes for older adults. Challenges, emerging therapies, and future directions are critically appraised to guide clinicians and healthcare systems in optimizing the role of nurses as frontline agents in geriatric assessment and health promotion.

Introduction

Intrinsic capacity (IC), as defined by the World Health Organization (WHO), refers to the composite of all physical and mental capacities that an individual can draw upon at any point in time. The paradigm shift from disease-centered to function-centered care in geriatrics underscores the importance of early identification and proactive management of IC decline. Nurse-led screening for IC in community settings is gaining traction for its scalability, cost-effectiveness, and ability to engage high-risk older adults outside traditional clinical environments. This article reviews the scientific basis, implementation strategies, and clinical relevance of nurse-led IC screening, aiming to provide a comprehensive resource for healthcare professionals seeking to enhance healthy aging initiatives.

Epidemiology / Disease Burden

The global population is rapidly aging, with the proportion of adults aged 60 years and older projected to double by 2050. Epidemiological studies indicate that declines in IC, manifesting as subtle impairments in mobility, cognition, sensory function, vitality, and psychological well-being, precede overt disability. According to recent WHO estimates, up to 30% of older adults in community settings exhibit early signs of IC decline, placing them at increased risk for frailty, dependency, hospitalization, and mortality. The burden is particularly pronounced in low- and middle-income countries, where access to specialized geriatric care is limited, underscoring the need for accessible, nurse-led screening models.

Pathophysiology

Intrinsic capacity is shaped by complex interactions between genetic, environmental, and lifestyle factors influencing physiological reserve across multiple domains. Aging-related changes in neuromuscular function, mitochondrial efficiency, inflammation, hormonal regulation, and neuroplasticity contribute to progressive declines in IC. Chronic diseases such as diabetes, cardiovascular disease, and neurodegenerative disorders further accelerate this decline through mechanisms involving oxidative stress, vascular dysfunction, and impaired cellular repair. Understanding these mechanisms provides a scientific rationale for multidimensional screening and targeted interventions aimed at preserving or restoring IC.

Risk Factors

Several modifiable and non-modifiable risk factors contribute to IC decline. These include advanced age, multimorbidity, polypharmacy, sedentary lifestyle, poor nutrition, social isolation, low educational attainment, and limited access to healthcare. Inflammatory biomarkers, sarcopenia, subclinical cognitive impairment, and depression are increasingly recognized as early indicators of declining IC. Nurse-led screening protocols are designed to identify these risk factors in community-dwelling older adults, enabling timely preventive and therapeutic strategies.

Clinical Features

Declining intrinsic capacity is clinically heterogeneous, often presenting as insidious deficits in mobility (slowed gait, balance impairment), cognition (memory lapses, executive dysfunction), sensory functions (hearing and vision loss), vitality (fatigue, weight loss), and psychological health (depression, anxiety). These features frequently overlap with geriatric syndromes such as frailty and early dementia. Early identification through systematic screening is crucial for differentiating reversible conditions from progressive decline, guiding appropriate referral and intervention pathways.

Diagnosis

Diagnosis of IC decline relies on comprehensive assessment tools that quantify function across multiple domains. The WHO ICOPE (Integrated Care for Older People) screening tool is widely validated for use by nurses in community settings. It encompasses structured questionnaires, performance-based measures (e.g., gait speed, grip strength), and cognitive screening tests (e.g., Mini-Cog, MoCA). Standardized protocols ensure reproducibility and facilitate longitudinal monitoring. Integration with electronic health records and telehealth platforms further enhances diagnostic accuracy and continuity of care.

Treatment & Management

Management of IC decline is inherently multidisciplinary, centering on personalized interventions tailored to identified deficits. Nurse-led care models focus on health education, exercise prescription, nutritional counseling, medication review, psychosocial support, and coordination with primary care physicians and allied health professionals. Early intervention can delay or reverse functional decline, prevent falls, reduce hospitalization, and maintain independence. Ongoing monitoring and adaptive care plans are essential for optimizing outcomes in dynamic community environments.

Recent Advances / Emerging Therapies

Recent advances include the development of digital IC assessment platforms, wearable sensors for remote monitoring, and artificial intelligence-driven risk stratification. Innovative nurse-led programs leverage group-based interventions, telehealth, and community partnerships to enhance screening coverage and intervention uptake. Emerging therapies targeting sarcopenia, cognitive impairment, and inflammation hold promise for directly modifying the biological underpinnings of IC decline. Ongoing clinical trials are evaluating the effectiveness of multimodal interventions, including physical activity, cognitive training, and nutritional supplementation, in preserving IC among older adults.

Guideline Recommendations

International guidelines, including those from WHO and the International Association of Gerontology and Geriatrics (IAGG), endorse routine IC screening in adults aged 60 and above, with a strong emphasis on nurse-led, community-based approaches. Recommendations highlight the importance of training nurses in geriatric assessment, standardizing screening protocols, integrating assessments within primary care, and ensuring linkage to multidisciplinary interventions. Adaptation to local healthcare contexts and ongoing evaluation of program effectiveness are critical for sustainable implementation.

Conclusion

Nurse-led intrinsic capacity screening in community settings represents a pivotal strategy for early identification and proactive management of functional decline among older adults. By leveraging the accessibility and expertise of nurses, healthcare systems can extend the reach of geriatric assessment, inform personalized care, and ultimately promote healthy aging at the population level. Continued research, innovation, and policy support are essential to optimize implementation and maximize the benefits of this transformative approach to geriatric care.